Video

(AAO) Alcon showcases advanced IOL technology for presbyopia

Author(s):

OT Staff Reports
Conferences|AAO

Kristen Brotherson, vice president, US surgical marketing for Alcon, discusses some of the recent advances in cataract surgery-related technologies, including a new advanced lens for patients with presbyopia (AcrySof IQ Vivity IOL).


Kristen Brotherson, vice president, US surgical marketing for Alcon, discusses some of the recent advances in cataract surgery-related technologies, including a new advanced lens for patients with presbyopia (AcrySof IQ Vivity IOL).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
Related Content
Q&A: Updates on faricimab for DME from ASRS 2025
August 1st 2025

Q&A: Updates on faricimab for DME from ASRS 2025

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 1st 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

What to expect from ASRS 2025
August 1st 2025

What to expect from ASRS 2025

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
August 1st 2025

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Alkeus Pharmaceuticals to present TEASE and SAGA study data at ASRS 2025
August 1st 2025

Alkeus Pharmaceuticals to present TEASE and SAGA study data at ASRS 2025

(Image credit: AdobeStock/Bonsales) Q&A: Natalie Afshari, MD, FACS, on-label pediatric IOLs: turning advocacy into access
August 1st 2025

Q&A: Natalie Afshari, MD, FACS, championing on-label pediatric IOLs: turning advocacy into access

© 2025 MJH Life Sciences

All rights reserved.